Estonia

GSK is a global biopharma company with the ambition and purpose to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people over the next 10 years.

Our innovation and R&D focusses on four therapeutic areas: infectious diseases, HIV, oncology, and immunology.

In Estonia, we work with our partners to deliver medicines and vaccines to patients.

Contact details

Expand all

For medical information

Tel:+37 28 002 640
Email:estoniansafety@gsk.com

Back to top

To report an adverse event

Tel:

+37 28 00 2640

Email:

estoniansafety@gsk.com

Or report directly to Regulatory Authority:

www.ravimiamet.ee

Back to top

For questions on our Ellipta and Nucala portfolio

Please contact Berlin-Chemie Menarini
Tel: +37 26 675 001

Back to top

For questions on supply and distribution of all other GSK medicines and vaccines

Please contact Tamro
Tel:+37 25 159 915

Back to top

For government and media enquiries

Please contact: ww.ceeurope-media@gsk.com

Back to top

For any other enquires

Tel: +37 28 002 640

Back to top

EFPIA disclosure

GSK fully supports the European Federation of Pharmaceutical Industries and Associations (EFPIA) Code on the disclosure of individual transfer of value from pharmaceutical companies to healthcare professionals and healthcare organisations.

We believe that it helps to create a better understanding about how the pharmaceutical industry partners and collaborates with HCPs and HCOs, and so increase confidence in the way that industry and the healthcare professions work together.

We publish disclosure reports in line with the EFPIA Code on the disclosure of individual transfers of value from pharmaceutical companies to healthcare professionals and healthcare organisations.

View our disclosure report for Estonia

Back to top